Latanoprost属于前列腺素F2α类似物，现已由美国FDA批准用于开角型青光眼、且以其它药物难以治疗的眼内压过高的病人的局部治疗。在美国，最广泛用于治疗青光眼的局用药剂为β－阻滞剂，其作用在于减少房水的形成从而降低限内压，几乎没有局部不良反应，也不妨碍视力，不过全 Latanoprost, a prostaglandin F2α analog, is now approved by the U.S. FDA for topical treatment of open-angle glaucoma in patients with intraocular hypertension who are refractory to other medications. In the United States, the most widely used agent for the treatment of glaucoma is beta-blocker, which acts to reduce the formation of aqueous humor and thereby reduce the internal pressure limit, with few or no adverse side effects, without compromising vision